Stephen Gottschalk, M.D., is the Chair of the Department of Bone Marrow Transplantation and Cellular Therapy at St Jude Children’s Research Hospital. Dr. Gottschalk is leading a team of MD and PhD researchers, who are actively conducting clinical studies with antigen-specific T cells for patients with hematological malignancies, brain and solid tumors. His research areas of interest are cancer immunotherapy, cell therapy and stem cell transplantation. In the laboratory, his team is focused on using genetic approaches to improve T-cell therapy for cancer. Prior to joining St Jude’s in 2017, he was a Professor at the Center for Cell and Gene Therapy at Texas Children’s Hospital and Baylor College of Medicine. Dr. Gottschalk earned an M.D. from Georg August University, Göttingen, Germany, and completed his internship in pediatric medicine at the University of Münster, Germany. He subsequently completed a residency in pediatrics and a fellowship in pediatric hematology-oncology at Baylor College of Medicine, Houston, Texas. For his contributions to the fields of pediatric hematopoietic stem cell transplantation and cell-based immunotherapies he was elected into the American Society of Clinical Investigation in 2015.